Varenicline Kit
Product Images NDC 14445-155

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 14445-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Indoco Remedies Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1 (Figure 1)

A bar chart comparing Varenicline at different strengths and placebo across multiple studies. The chart displays percentage values on the vertical axis, with study labels (Study 2, Study 3, Study 4, Study 5) on the horizontal axis, illustrating treatment effects with bars for Varenicline 0.5 mg, 1 mg, and placebo groups with error bars indicating variability.*

FDA Label Image

Fig 2 (Figure 2)

A bar chart presenting data from five studies comparing different doses and forms of Varenicline tartrate tablets (0.5 mg and 1 mg) and placebos. The chart shows comparative percentages with error bars for each study group, indicating variability or confidence intervals. Study groups include Varenicline 0.5 mg, Varenicline 1.0 mg, Varenicline Flexible, Varenicline SR 150 mg BID, Bupropion SR 150 mg BID, and Placebo.*

FDA Label Image

Fig 3 (Figure 3)

A line graph depicting the percentage of continuous abstinent participants over time during nontreatment follow-up weeks, comparing Varenicline 1.0 mg BID and placebo groups. The x-axis represents weeks of follow-up, while the y-axis shows the percent continuous abstinent.*

FDA Label Image

Structure (Structure)

Chemical structure of varenicline tartrate, showing the molecular arrangement of the varenicline molecule combined with the tartrate moiety.*

FDA Label Image

Vareni-container-label-1mg (Vareni Container Label 1mg)

Label for Varenicline Tablets 1 mg by Indoco Remedies Limited. The film-coated oral tablet packaging indicates each tablet contains 1 mg of varenicline. The label includes storage instructions, dosage information, a barcode, and states the package contains 56 tablets. It also advises dispensing the enclosed medication guide to each patient.*

FDA Label Image

Vareni-container-label-0-5mg (Vareni Container Label mg)

Label for Varenicline Tablets 0.5 mg, a human prescription oral film-coated tablet by Indoco Remedies Limited. The label includes storage instructions, dosage information, a barcode, and a count of 56 tablets. It highlights that each tablet contains 0.85 mg varenicline tartrate equivalent to 0.5 mg varenicline free base.*

FDA Label Image

Vareni-continuing-carton-label (Vareni Continuing Carton Label)

Packaging label for Varenicline Tablets, a 1 mg oral film-coated tablet by Indoco Remedies Limited. The label indicates a continuing month box containing 4 continuing weeks of therapy, with 56 tablets total (1 mg each). It includes storage instructions, dosage guidance, manufacturer details, and a barcode.*

FDA Label Image

Vareni-continuing-pack-blister (Vareni Continuing Pack Blister)

Packaging label for Varenicline Tablets Continuing Pack, containing 56 film-coated tablets at a strength of 1 mg each, manufactured by Indoco Remedies Limited. The label includes a detailed tablet blister layout marked by days and doses, storage instructions at 25°C, dosage information, and a barcode. The label displays the NDC number 14445-156-02 and Rx only designation.*

FDA Label Image

Vareni-starting-carton-label (Vareni Starting Carton Label)

Varenicline Tablets starting month box carton label showing dosage strengths of 0.5 mg and 1 mg film-coated oral tablets by Indoco Remedies Limited. The label details blister pack contents of 11 tablets of 0.5 mg strength and 42 tablets of 1 mg strength, with instructions for use over the first 28 days. Storage instructions and manufacturer address in Goa, India, are also included.*

FDA Label Image

Vareni-starting-pack-blister (Vareni Starting Pack Blister)

Varenicline tartrate starting pack blister card with film-coated tablets in dosages of 0.5 mg and 1 mg. The packaging is labeled for oral use and includes detailed dosage instructions for starting and continuing weeks, manufacturer Indoco Remedies Limited, and storage information. The cardboard features both green and blue areas with tablet slots numbered by day and time (morning/evening).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.